Abraxis BioScience, Inc.
Overview
Abraxis BioScience, a subsidiary of Celgene Corporation, specializes in the development and commercialization of therapeutics for critical illnesses. Known for its innovative approach to drug delivery systems, particularly in oncology, Abraxis contributes significantly to cancer treatment advancements.
Therapeutic areas
OncologyCritical Illness
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Abraxis BioScience, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.